Structure of human Fyn kinase domain complexed with staurosporine

被引:53
作者
Kinoshita, Takayoshi
Matsubara, Mamoru
Ishiguro, Hiroshi
Okita, Kouki
Tada, Toshiji
机构
[1] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Sakai, Osaka 5998531, Japan
[2] Carna Biosci, Chuo Ku, Kobe, Hyogo 6500047, Japan
关键词
Fyn; kinase domain; non-receptor tyrosine kinase; Src family; staurosporine; inhibitor; X-ray crystal structure;
D O I
10.1016/j.bbrc.2006.05.212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tyrosine kinase Fyn is a member of the Src kinase family. Besides the role of Fyn in T cell signal transduction in concert with Lck, its excess activity in the brain is involved with conditions such as Alzheimer's and Parkinson's diseases. Therefore, inhibition of Fyn kinase may help counteract these nervous system disorders. Here, we solved the crystal structure of the human Fyn kinase domain complexed with staurosporine, a potent kinase inhibitor, at 2.8 angstrom resolution. Staurosporine binds to the ATP-binding site of Fyn in a similar manner as in the Lck- and Csk-complexes. The small structural differences in the staurosporine-binding and/or -unbinding region among the three kinase domains may help obtaining the selective inhibitors against the respective kinases. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:840 / 844
页数:5
相关论文
共 18 条
  • [1] Regulation, substrates and functions of src
    Brown, MT
    Cooper, JA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3): : 121 - 149
  • [2] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [3] Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection
    Burchat, A
    Borhani, DW
    Calderwood, DJ
    Hirst, GC
    Li, BQ
    Stachlewitz, RF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (01) : 118 - 122
  • [4] Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights
    Cherry, M
    Williams, DH
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (06) : 663 - 673
  • [5] Fyn kinase induces synaptic and cognitive impairments in a Transgenic mouse model of Alzheimer's disease
    Chin, J
    Palop, JJ
    Puoliväli, J
    Massaro, C
    Bien-Ly, N
    Gerstein, H
    Scearce-Levie, K
    Masliah, E
    Mucke, L
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (42) : 9694 - 9703
  • [6] PROTEIN KINASES .6. THE EUKARYOTIC PROTEIN-KINASE SUPERFAMILY - KINASE (CATALYTIC) DOMAIN-STRUCTURE AND CLASSIFICATION
    HANKS, SK
    HUNTER, T
    [J]. FASEB JOURNAL, 1995, 9 (08) : 576 - 596
  • [7] Fyn is required for haloperidol-induced catalepsy in mice
    Hattori, K
    Uchino, S
    Isosaka, T
    Maekawa, M
    Iyo, M
    Sato, T
    Kohsaka, S
    Yagi, T
    Yuasa, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (11) : 7129 - 7135
  • [8] Cubanecarboxylic acids.: Crystal engineering considerations and the role of C-H•••O hydrogen bonds in determining O-H•••O networks
    Kuduva, SS
    Craig, DC
    Nangia, A
    Desiraju, GR
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (09) : 1936 - 1944
  • [9] Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine
    Lamers, MBAC
    Antson, AA
    Hubbard, RE
    Scott, RK
    Williams, DH
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (02) : 713 - 725
  • [10] Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn
    Löwenberg, M
    Tuynman, J
    Bilderbeek, J
    Gaber, T
    Buttgereit, F
    van Deventer, S
    Peppelenbosch, M
    Hommes, D
    [J]. BLOOD, 2005, 106 (05) : 1703 - 1710